1.
Arab Journal of Pharmaceutical Sciences. 2003; 2 (6): 11-20
en Arabe
| IMEMR
| ID: emr-61579
RESUMEN
The goal of this study was to evaluate the anti-tumor activity of two Enkephalin analogues designed and synthesized using a conventional solution method. The anti-tumor activity of these two analogues was studied in-vitro following National cancer institute [NCI] protocol [USA]. The results confirmed that the synthesized Leu- Enkephalin analogue [analogue 1] have a positive effect on all cell lines tested indicating its effectiveness as anti-tumor compound on many cancers especially those of lungs, colon and breast. Met-Enkephalin analogue [ana1ogue II] showed no effect on any type of tumor cells tested. In conclusion analogue I can be considered as a novel promising anticancer compound
Asunto(s)
Encefalinas , Encefalinas/análogos & derivados , Antineoplásicos , Encefalina Leucina , Encefalina Metionina
2.
Indian J Biochem Biophys
;
1988 Aug; 25(4): 356-9
Artículo
en Inglés
| IMSEAR
| ID: sea-27462